comparemela.com

Latest Breaking News On - Lifestance health group price performance - Page 1 : comparemela.com

Brown Advisory Inc Purchases 1,062,887 Shares of LifeStance Health Group, Inc (NASDAQ:LFST)

Brown Advisory Inc. boosted its position in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 25.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,158,980 shares of the company’s stock after purchasing an additional 1,062,887 shares during the quarter. Brown Advisory Inc. […]

LifeStance Health Group, Inc (NASDAQ:LFST) Insider Sells $76,882 45 in Stock

LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) insider Danish J. Qureshi sold 12,965 shares of the company’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $5.93, for a total transaction of $76,882.45. Following the completion of the transaction, the insider now owns […]

Jefferies Financial Group Boosts LifeStance Health Group (NASDAQ:LFST) Price Target to $9 00

LifeStance Health Group (NASDAQ:LFST – Free Report) had its price target upped by Jefferies Financial Group from $8.00 to $9.00 in a research report released on Wednesday morning, Benzinga reports. Jefferies Financial Group currently has a buy rating on the stock. Several other research firms have also recently commented on LFST. Barclays boosted their price […]

LifeStance Health Group (LFST) Set to Announce Quarterly Earnings on Wednesday

LifeStance Health Group (NASDAQ:LFST – Get Free Report) is set to release its 12/31/2023 earnings data before the market opens on Wednesday, February 28th. Analysts expect LifeStance Health Group to post earnings of ($0.09) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this […]

LifeStance Health Group, Inc (NASDAQ:LFST) Given Consensus Rating of Moderate Buy by Brokerages

LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) has earned an average recommendation of “Moderate Buy” from the seven analysts that are covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.